2750 Stock Overview
Kunming Longjin Pharmaceutical Co., Ltd. therapeutic medicines for people living with cardiovascular, cerebrovascular, and metabolic diseases in China.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 3/6 |
| Dividends | 0/6 |
Kunming Longjin Pharmaceutical Co., Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CN¥5.87 |
| 52 Week High | CN¥12.50 |
| 52 Week Low | CN¥4.66 |
| Beta | 0.30 |
| 1 Month Change | -18.70% |
| 3 Month Change | 12.24% |
| 1 Year Change | -40.83% |
| 3 Year Change | -23.27% |
| 5 Year Change | -61.53% |
| Change since IPO | 15.32% |
Recent News & Updates
Risks Still Elevated At These Prices As Kunming Longjin Pharmaceutical Co., Ltd. (SZSE:002750) Shares Dive 26%
Apr 26
We're Not Very Worried About Kunming Longjin Pharmaceutical's (SZSE:002750) Cash Burn Rate
Apr 17Revenues Not Telling The Story For Kunming Longjin Pharmaceutical Co., Ltd. (SZSE:002750) After Shares Rise 29%
Mar 08Recent updates
Risks Still Elevated At These Prices As Kunming Longjin Pharmaceutical Co., Ltd. (SZSE:002750) Shares Dive 26%
Apr 26We're Not Very Worried About Kunming Longjin Pharmaceutical's (SZSE:002750) Cash Burn Rate
Apr 17Revenues Not Telling The Story For Kunming Longjin Pharmaceutical Co., Ltd. (SZSE:002750) After Shares Rise 29%
Mar 08Shareholder Returns
| 2750 | CN Pharmaceuticals | CN Market | |
|---|---|---|---|
| 7D | 2.1% | 2.7% | 1.2% |
| 1Y | -40.8% | -10.9% | -12.6% |
Return vs Industry: 002750 underperformed the CN Pharmaceuticals industry which returned -10.9% over the past year.
Return vs Market: 002750 underperformed the CN Market which returned -12.6% over the past year.
Price Volatility
| 2750 volatility | |
|---|---|
| 2750 Average Weekly Movement | 11.3% |
| Pharmaceuticals Industry Average Movement | 7.1% |
| Market Average Movement | 8.3% |
| 10% most volatile stocks in CN Market | 12.1% |
| 10% least volatile stocks in CN Market | 5.0% |
Stable Share Price: 002750's share price has been volatile over the past 3 months.
Volatility Over Time: 002750's weekly volatility (11%) has been stable over the past year, but is still higher than 75% of CN stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1996 | 262 | n/a | www.longjin.com.cn |
Kunming Longjin Pharmaceutical Co., Ltd. therapeutic medicines for people living with cardiovascular, cerebrovascular, and metabolic diseases in China. The company offers medicines in the areas of cardiovascular and cerebrovascular, digestive system, vitamin, minerals and enteral nutrition, and immunology, as well as first aid kits; extracts of natural plants, such as breviscapine; and industrial hemp consumer products. It also engages in the industrial hemp plantation business.
Kunming Longjin Pharmaceutical Co., Ltd. Fundamentals Summary
| 2750 fundamental statistics | |
|---|---|
| Market cap | CN¥2.35b |
| Earnings (TTM) | -CN¥67.32m |
| Revenue (TTM) | CN¥91.46m |
25.7x
P/S Ratio-34.9x
P/E RatioIs 2750 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 2750 income statement (TTM) | |
|---|---|
| Revenue | CN¥91.46m |
| Cost of Revenue | CN¥35.32m |
| Gross Profit | CN¥56.14m |
| Other Expenses | CN¥123.45m |
| Earnings | -CN¥67.32m |
Last Reported Earnings
Mar 31, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.17 |
| Gross Margin | 61.38% |
| Net Profit Margin | -73.60% |
| Debt/Equity Ratio | 1.9% |
How did 2750 perform over the long term?
See historical performance and comparison